[Infection prevention in the patient undergoing hematopoietic stem cell transplantation].
Baro
J
J
Servicio de Hematología, Hospital Universitario Marqués de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander.
Richard
C
C
Zubizarreta
A
A
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control; D006085:Graft Survival; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D017053:Infection Control / Q000379:methods*; D010198:Pancytopenia / Q000150:complications; D011292:Premedication; D012307:Risk Factors; D013997:Time Factors; D019172:Transplantation Conditioning / Q000009:adverse effects
D000890:Anti-Infective Agents; D016298:Hematopoietic Cell Growth Factors